Global Health Limited, widely recognized through its flagship brand Medanta – The Medicity, is one of India’s leading private healthcare providers. Renowned for its world-class medical services, Global Health operates a network of multi-specialty hospitals that deliver high-quality healthcare across a wide range of specialties. The company is dedicated to transforming the healthcare landscape in India through cutting-edge technology, advanced medical research, and a patient-centric approach. As of December, 04, 2024, the Global Health share price on the NSE is ₹1154. Below are the projected Global Health share price target for the years 2024, 2025, 2026, 2027, 2030, 2035 And 2040.
Additionally, feel free to join our – Tele-(g)ram) where we share Fast stock market news and updates➥https://bit.ly/TradeWatch360
Medanta Global Health Company Overview
Established in 2009 by renowned cardiovascular surgeon Dr. Naresh Trehan, Global Health Limited is headquartered in Gurugram, Haryana. The company’s flagship facility, Medanta – The Medicity, is a state-of-the-art tertiary care hospital offering services across over 30 specialties, including cardiology, oncology, orthopedics, neurology, and organ transplantation.
| Company type | Public |
| Traded as | NSE: MEDANTA BSE: 543654 |
| ISIN | INE882T01013 |
| Industry | Healthcare |
| Founded | 2009; 15 years ago |
| Founders | Naresh Trehan Sunil Sachdeva |
| Headquarters | Gurgaon, Haryana, India |
| Areas served | India |
| Key people | Naresh Trehan (Chairman) Pankaj Sahni (CEO) |
| Services | HospitalsClinics |
| Revenue | ₹3,349 crore(US$400 million) (FY24) |
| Operating income | ₹873 crore(US$100 million) (FY24) |
| Net income | ₹478 crore(US$57 million) (FY24) |
| Website | www.medanta.org |
Global Health Share Price Target 2025-2040 Forecast
| Year | Year High Target (₹) | Year Low Target (₹) | Year-End Target (₹) |
| 2024 | 1500 | 900 | 1320 |
| 2025 | 1780 | 1130 | 1460 |
| 2026 | 2150 | 1360 | 1650 |
| 2027 | 2420 | 1540 | 2100 |
| 2028 | 2760 | 1850 | 2450 |
| 2029 | 3050 | 2230 | 2850 |
| 2030 | 3470 | 2560 | 3240 |
| 2035 | 5750 | 2950 | 5200 |
| 2040 | 8150 | 4860 | 7950 |
Technical Analysis for Global Health
Global Health Share Price Target 2025
| Year | 1st Target | 2nd Target |
| 2025 | 1600 | 1780 |
Global Health is anticipated to perform strongly in 2025, leveraging its robust healthcare infrastructure and growing demand for high-quality medical services. The share price is projected to reach a first target of ₹1600 and a second target of ₹1780, reflecting its solid growth outlook.
Read More:- CEAT Share Price in 1990 to 2040
Global Health Share Price Target 2026
| Year | 1st Target | 2nd Target |
| 2026 | 2000 | 2150 |
In 2026, the company is expected to expand its operations and enhance service delivery, driving financial performance. The share price is likely to achieve a first target of ₹2000 and a second target of ₹2150, supported by consistent operational efficiency.
Global Health Share Price Target 2027
| Year | 1st Target | 2nd Target |
| 2027 | 2250 | 2420 |
By 2027, Global Health is poised to benefit from its continued investments in advanced medical technology and healthcare infrastructure. The share price is forecasted to reach ₹2250 for the first target and ₹2420 for the second target, showcasing its sustained growth trajectory.
Global Health Share Price Target 2028
| Year | 1st Target | 2nd Target |
| 2028 | 2600 | 2760 |
In 2028, the company’s focus on innovation and expansion is expected to boost its market presence further. The share price is projected to achieve a first target of ₹2600 and a second target of ₹2760, underlining its upward momentum.
Global Health Share Price Target 2029
| Year | 1st Target | 2nd Target |
| 2029 | 2900 | 3050 |
Global Health’s strategic initiatives and market demand are expected to drive its performance in 2029. The share price is estimated to hit ₹2900 for the first target and ₹3050 for the second target, reflecting continued investor confidence.
Global Health Share Price Target 2030
| Year | 1st Target | 2nd Target |
| 2030 | 3280 | 3470 |
By 2030, the company is likely to establish itself as a leading healthcare provider in the region. The share price is forecasted to reach ₹3280 for the first target and ₹3470 for the second target, highlighting its consistent financial and operational success.
Global Health Share Price Target 2035
| Year | 1st Target | 2nd Target |
| 2035 | 4800 | 5750 |
Over the next decade, Global Health’s focus on scaling its operations and delivering high-quality care is expected to drive significant value. By 2035, the share price is projected to reach ₹4800 for the first target and ₹5750 for the second target, signaling its long-term growth potential.
Read More:- Mphasis Share Price Target 2025, 2030, 2035, 2040
Global Health Share Price Target 2040
| Year | 1st Target | 2nd Target |
| 2040 | 7400 | 8150 |
By 2040, Global Health is expected to emerge as a prominent player in the global healthcare industry, delivering strong returns for its investors. The share price is anticipated to achieve a first target of ₹7400 and a second target of ₹8150, underscoring its robust growth prospects.
Global Health Ltd Fundamentals
| Parameter | Value |
| Market Cap | ₹30,592Cr |
| P/E Ratio (TTM) | 80.44 |
| P/B Ratio | 10.04 |
| Industry P/E | 33.31 |
| Debt to Equity | 0.07 |
| ROE | 12.48% |
| EPS (TTM) | 14.16 |
| Dividend Yield | 0.00% |
| 52 Week High | ₹1514 |
| 52 Week Low | ₹908 |
| Book Value | 113.50 |
| Face Value | 2 |
Global Health Ltd Financial Results
| All in ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
| Sales | 1,447 | 2,167 | 2,694 | 3,275 | 3,463 |
| Expenses | 1,250 | 1,709 | 2,073 | 2,476 | 2,653 |
| Operating Profit | 197 | 458 | 621 | 799 | 810 |
| OPM % | 14% | 21% | 23% | 24% | 23% |
| Other Income | 31 | 39 | 64 | 75 | 86 |
| Interest | 73 | 86 | 86 | 74 | 70 |
| Depreciation | 123 | 130 | 150 | 173 | 185 |
| Profit before tax | 32 | 281 | 449 | 627 | 640 |
| Tax % | 11% | 30% | 27% | 24% | |
| Net Profit | 29 | 196 | 326 | 478 | 488 |
| EPS in Rs | 5.81 | 7.75 | 12.16 | 17.81 | 18.18 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
Global Health Balance Sheet
| All in ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
| Equity Capital | 50 | 51 | 54 | 54 | 54 |
| Reserves | 1,333 | 1,565 | 2,375 | 2,852 | 3,088 |
| Borrowings | 931 | 1,109 | 1,122 | 802 | 688 |
| Other Liabilities | 380 | 421 | 547 | 597 | 680 |
| Total Liabilities | 2,694 | 3,146 | 4,097 | 4,304 | 4,510 |
| Fixed Assets | 1,616 | 1,776 | 2,050 | 2,237 | 2,464 |
| CWIP | 464 | 439 | 327 | 386 | 453 |
| Investments | 0 | 0 | 0 | 0 | 3 |
| Other Assets | 615 | 930 | 1,720 | 1,681 | 1,590 |
| Total Assets | 2,694 | 3,146 | 4,097 | 4,304 | 4,510 |
Global Health Ltd Shareholding Pattern
| Mar 2023 | Mar 2024 | Sep 2024 | |
| Promoters | 33.08% | 33.04% | 33.04% |
| FIIs | 9.89% | 12.10% | 12.21% |
| DIIs | 12.34% | 10.25% | 11.11% |
| Public | 44.67% | 44.60% | 43.64% |
| No. of Shareholders | 1,07,120 | 1,66,253 | 1,49,722 |
Global Health Peers comparison
| Sector: Healthcare | Industry: Healthcare | ||||
| Name | P/E | Mar Cap₹Cr. | Div Yld% | NP Qtr₹Cr. | ROCE% |
| Apollo Hospitals | 87.25 | 103206.50 | 0.22 | 395.70 | 15.11 |
| Max Healthcare | 95.86 | 101519.73 | 0.15 | 281.81 | 16.00 |
| Fortis Health. | 77.41 | 53247.18 | 0.14 | 193.08 | 10.34 |
| Global Health | 63.44 | 30953.36 | 0.00 | 130.81 | 19.32 |
| Poly Medicure | 98.30 | 28974.59 | 0.11 | 87.45 | 23.62 |
| Narayana Hrudaya | 34.01 | 26515.79 | 0.30 | 198.80 | 26.54 |
| Dr Lal Pathlabs | 61.59 | 24739.47 | 0.81 | 130.80 | 25.17 |
FAQs
Q1: Global Health Share Price Target 2025?
Ans: For 2025, the share price of Global Health Ltd is anticipated to reach ₹1600 as the first target and ₹1780 as the second target, reflecting its continued growth in the healthcare and hospital management sectors.
Q2: Global Health Share Price Target 2026?
Ans: The projected share price for 2026 is ₹2000 as the first target and ₹2150 as the second target, driven by expanding operations and increased demand for healthcare services.
Q3: Global Health Share Price Target 2027?
Ans: In 2027, the share price is expected to achieve ₹2250 as the first target and ₹2420 as the second target, supported by the company’s steady operational growth and service innovations.
Q4: Global Health Share Price Target 2028?
Ans: For 2028, the share price is forecasted to reach ₹2600 as the first target and ₹2760 as the second target, reflecting improved financial performance and strategic expansion.
Q5: Global Health Share Price Target 2029?
Ans: By 2029, the share price is anticipated to reach ₹2900 as the first target and ₹3050 as the second target, showcasing consistent growth driven by increased healthcare demand.
Q6: Global Health Share Price Target 2030?
Ans: The projected share price for 2030 is ₹3280 as the first target and ₹3470 as the second target, supported by sustained revenue growth and operational efficiency.
Q7: Global Health Share Price Target 2035?
Ans: For 2035, the share price is expected to achieve ₹4800 as the first target and ₹5750 as the second target, reflecting strong long-term growth potential in the healthcare sector.
Q8: Global Health Share Price Target 2040?
Ans: By 2040, the share price is projected to reach ₹7400 as the first target and ₹8150 as the second target, highlighting the company’s leadership in the healthcare industry and its ability to adapt to changing market dynamics.
Q9: What is the NSE and BSE code for Global Health Ltd?
Ans: Global Health Ltd. operates under the Medanta brand. The NSE symbol for Global Health Ltd. is MEDANTA. The BSE code for Global Health Ltd. is 543654.
Q10: Who is the CEO of Global Health?
Ans: The current CEO of Global Health Ltd. is Michael Davies. He has been leading the company since July 2021, succeeding Mathew Cherian, who transitioned to an Executive Director role.
TradeWatch360 is a premier platform dedicated to providing real-time insights, trends, and updates in the stock market. It is designed to support both new and seasoned investors by delivering timely and actionable information across a range of asset classes, including stocks, futures, commodities, and global markets.